These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19919393)

  • 1. The surge of Japanese studies supporting the use of angiotensin receptor blockers in hypertension.
    Kjeldsen SE; Narkiewicz K; Hedner T
    Blood Press; 2009; 18(5):240-1. PubMed ID: 19919393
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin receptor blockers: baseline therapy in hypertension?
    Messerli FH; Bangalore S; Ruschitzka F
    Eur Heart J; 2009 Oct; 30(20):2427-30. PubMed ID: 19723696
    [No Abstract]   [Full Text] [Related]  

  • 3. [VALISH].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():454-8. PubMed ID: 16981579
    [No Abstract]   [Full Text] [Related]  

  • 4. Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
    Minami J; Ohno E; Furukata S; Ishimitsu T; Matsuoka H
    J Hum Hypertens; 2009 Oct; 23(10):683-6. PubMed ID: 19369955
    [No Abstract]   [Full Text] [Related]  

  • 5. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract]   [Full Text] [Related]  

  • 6. [Convincing results from the JIKEI Study].
    MMW Fortschr Med; 2006 Dec; 148(51-52):55. PubMed ID: 17619349
    [No Abstract]   [Full Text] [Related]  

  • 7. [Risk oriented therapy of hypertension. Lowering blood pressure and risk].
    MMW Fortschr Med; 2007 Nov; 149(46):53. PubMed ID: 18069196
    [No Abstract]   [Full Text] [Related]  

  • 8. [Successful mega studies with heart patients. Valsartan possesses cardioprotective action].
    MMW Fortschr Med; 2006 Feb; 148(5):48-9. PubMed ID: 16518941
    [No Abstract]   [Full Text] [Related]  

  • 9. [Scientific evidence--applied in routine general practice. Successful decrease in pressure and risk].
    MMW Fortschr Med; 2006 May; 148(18):42-3. PubMed ID: 16736689
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics.
    Epstein M; Hollenberg NK
    Am J Hypertens; 2004 Jul; 17(7):638-9; author reply 639-40. PubMed ID: 15233985
    [No Abstract]   [Full Text] [Related]  

  • 11. Sartans for hypertension--implications of the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial.
    Cheung BM
    Hong Kong Med J; 2004 Oct; 10(5):359. PubMed ID: 15479968
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trial rigging: again!
    Prescrire Int; 2014 Apr; 23(148):110. PubMed ID: 24860906
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
    Roger N; Popovic I; Madelenat P; Mahieu-Caputo D
    Gynecol Obstet Fertil; 2007 Jun; 35(6):556-60. PubMed ID: 17544313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [AT1 blocker or calcium antagonist in treatment of hypertension. What protects the heart better?].
    Einecke D
    MMW Fortschr Med; 2004 Jun; 146(26):12. PubMed ID: 15529682
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypertension and diabetic nephropathy, a dangerous duo].
    Hausberg M; Hohage H; Kosch M
    Med Klin (Munich); 2005 Nov; 100(11):729-37; quiz 738-9. PubMed ID: 16328181
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preventing end-organ damage in hypertension. What is the significance of the VALUE Study for general practice?].
    Zidek W
    MMW Fortschr Med; 2004 Jul; 146(27-28):41. PubMed ID: 15526662
    [No Abstract]   [Full Text] [Related]  

  • 17. Hope in Life and Value of blood pressure control.
    Ruilope LM; Segura J
    J Hypertens; 2004 Dec; 22(12):2265-6. PubMed ID: 15614017
    [No Abstract]   [Full Text] [Related]  

  • 18. Single-pill combination of amlodipine and valsartan in the management of hypertension.
    Flack JM; Hilkert R
    Expert Opin Pharmacother; 2009 Aug; 10(12):1979-94. PubMed ID: 19606937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study.
    Andrés A; Morales E; Morales JM; Bosch I; Campo C; Ruilope LM;
    Transplant Proc; 2006 Oct; 38(8):2419-23. PubMed ID: 17097955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of VALUE--a hypertension study which compared valsartan with amlodipine. New data support early, optimal blood pressure control for high-risk patients].
    Nilsson PM
    Lakartidningen; 2004 Jul; 101(30-31):2426-7. PubMed ID: 15314941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.